Guia Lumbalgia (cambios 8 feb).FH10 - Digemid

20.Vetter G, Bruggemann G, Lettko M, Schwieger G, Asbach H, Biermann W, Blasius K, BrinkmannR, Bruns H, Dorn E, et al. (1988) [Shortening diclofenac therapy by B vitamins. Results of arandomized double-blind study, diclofenac 50 mg versus diclofenac 50 mg plus B vitamins, inpainful spinal diseases with degenerative changes]. Z Rheumatol, 47(5): 351-62.21.Videman T, Osterman K (1984) Double-blind parallel study of piroxicam versus indomethacin inthe treatment of low back pain. Ann Clin Res, 16(3): 156-6022.Arbus L, Fajadet B, Aubert D, Morre M, Goldfinger E (1990) Activity of tetrazepam in low backpain. Clinical Trials Journal, 27(4): 258-67.23.Basmajian JV (1978) Cyclobenzaprine hydrochloride effect on skeletal muscle spasm in thelumbar region and neck: two double-blind controlled clinical and laboratory studies. Arch PhysMed Rehabil, 59(2): 58-63.24.Casale R (1988) Acute low back pain: Symptomatic treatment with a muscle relaxant drug. TheClinical Journal of Pain, 4: 81-8.25.Pipino F, Menarini C, Lombardi G, Guerzoni P, Ferrini A, Pizzoli A, Grangie A, Beltrame A, SorbilliG, Gottardo R, Cilento F (1991) A direct myotonolytic (Pridinol Mesilate) for the management ofchronic low back pain: A multicentre, comparative clinical evaluation. European Journal of ClinicalResearch, 1: 55-70.26.Pratzel HG, Alken RG, Ramm S (1996) Efficacy and tolerance of repeated oral doses of tolperisonehydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebocontrolleddouble-blind trial. Pain, 67(2-3): 417-25.27.Salzmann E, Pforringer W, Paal G, Gierend M (1992) Treatment of chronic low-back syndromewith tetrazepam in a placebo controlled double-blind trial. J Drug Dev, 4: 219-28.28.Worz R, Bolten W, Heller B, Krainick JU, Pergande G (1996) [Flupirtine in comparison withchlormezanone in chronic musculoskeletal back pain. Results of a multicenter randomized doubleblindstudy]. Fortschr Med, 114(35-36): 500-463 636.1.5 Intervención neurorreflejoterápica.RecomendaciónDerive a intervención neurorreflejoterápica (NRT) a los pacientes en los que estatecnología está indicada.IndicaciónPacientes en los que el dolor persiste tras 14 o más días de tratamiento farmacológico,con una intensidad 3 puntos en una escala analógica visual (cuyo rango va de 0–no dolor- a 10 –máximo dolor imaginable-).Síntesis de la evidenciaLa intervención NRT es eficaz y segura para el tratamiento de lalumbalgiaLa intervención NRT es efectiva y coste/efectiva para el tratamientode la lumbalgiaNivel ANivel C